Table of Contents
Table 5-70: Rush
Table 5-72: Scott
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 712 | 609.2 | 3,426 | 594.1 | 295 | 252.9 | 1,485 | 262.5 |
| Esophagus | 21 | 17.9 | 63 | 10.9 | 15 | 13.2** | 54 | 9.4 |
| Stomach | 21 | 17.8 | 63 | 11.0 | 10 | 8.5** | 33 | 5.7 |
| Colon excluding Rectum | 62 | 53.6 | 290 | 51.2 | 29 | 25.9 | 143 | 25.7 |
| Rectum and Rectosigmoid Junction | 17 | 14.7** | 117 | 20.6 | * | # | 16 | 2.9** |
| Liver | * | # | 18 | 3.0** | * | # | 22 | 3.7 |
| Pancreas | 22 | 18.2 | 96 | 16.8 | 20 | 17.7 | 85 | 15.0 |
| Lung and Bronchus | 108 | 93.9 | 607 | 106.0 | 91 | 77.5 | 495 | 86.8 |
| Melanoma of the Skin | 21 | 17.4 | 125 | 21.0 | 6 | 5.2** | 30 | 5.2 |
| Prostate | 200 | 172.3 | 917 | 159.6 | 27 | 24.2 | 163 | 30.0 |
| Urinary Bladder | 49 | 43.0 | 245 | 43.3 | 7 | 5.8** | 49 | 9.0 |
| Kidney and Renal Pelvis | 30 | 25.3 | 114 | 19.3 | 7 | 5.9** | 43 | 7.6 |
| Brain and Other Nervous System | 7 | 5.5** | 41 | 6.5 | 6 | 4.8** | 25 | 4.1 |
| Non-Hodgkin Lymphoma | 23 | 19.6 | 119 | 20.4 | 11 | 9.4** | 51 | 9.1 |
| Myeloma | * | # | 31 | 5.5 | * | # | 26 | 4.6 |
| Leukemia | 18 | 15.1** | 80 | 13.8 | 18 | 15.3** | 55 | 9.7 |
| Primary Site | Incidence | Mortality | ||||||
|---|---|---|---|---|---|---|---|---|
| 2003 | 1999 - 2003 | 2003 | 1999 - 2003 | |||||
| Count | Rate | Count | Rate | Count | Rate | Count | Rate | |
| All Sites | 636 | 409.3 | 3,320 | 436.1 | 264 | 156.5 | 1,384 | 169.2 |
| Colon excluding Rectum | 66 | 36.9 | 352 | 40.5 | 31 | 15.8 | 137 | 15.4 |
| Rectum and Rectosigmoid Junction | 10 | 5.1** | 62 | 7.7 | * | # | 11 | 1.4** |
| Liver | * | # | 8 | 1.0** | * | # | 10 | 1.2** |
| Pancreas | 13 | 7.8** | 89 | 11.1 | 11 | 6.1** | 79 | 9.3 |
| Lung and Bronchus | 96 | 61.6 | 458 | 59.8 | 58 | 36.5 | 350 | 44.4 |
| Melanoma of the Skin | 28 | 19.7 | 91 | 12.9 | * | # | 19 | 2.4** |
| Breast | 173 | 117.3 | 931 | 128.4 | 44 | 26.6 | 201 | 25.2 |
| Cervix Uteri | 8 | 6.7** | 52 | 8.0 | 6 | 4.0** | 23 | 3.3 |
| Corpus Uteri | 37 | 23.0 | 221 | 29.7 | * | # | 22 | 2.7 |
| Ovary | 15 | 10.6** | 131 | 17.7 | 16 | 9.6** | 82 | 10.1 |
| Urinary Bladder | 22 | 12.2 | 99 | 11.8 | 10 | 4.9** | 28 | 3.2 |
| Kidney and Renal Pelvis | 19 | 12.2** | 74 | 9.7 | 6 | 3.4** | 26 | 3.3 |
| Brain and Other Nervous System | 6 | 4.4** | 41 | 5.7 | 7 | 4.9** | 37 | 5.0 |
| Non-Hodgkin Lymphoma | 27 | 17.1 | 148 | 19.0 | 12 | 6.9** | 71 | 8.3 |
| Myeloma | 5 | 2.5** | 31 | 3.8 | 8 | 5.3** | 26 | 3.2 |
| Leukemia | 9 | 6.0** | 54 | 6.8 | 8 | 4.5** | 47 | 5.7 |
Rates are per 100,000; Age-adjusted, 2000 US Std Population (Census P25-1130).
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than 20 cases are unstable.
# Rate cannot be calculated.
Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, July 2006
Table of Contents
Table 5-70: Rush
Table 5-72: Scott
